Skip to main content

Advertisement

SpringerLink
Log in

Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi's sarcoma

  • Original Investigation
  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

Abstract

Oral candidiasis (OC) is a frequent oral manifestation of HIV infection, is a marker disease and occurs as a pseudomembranous, erythematous or rarely hyperplastic variant; angular cheilitis is also seen. Candida albicans is frequently isolated but other species such as C. krusei and C. dublienensis are emerging. Resistance against fluconazole is common. Bacterial oral infections are comparatively rare and are predominantly localized to the gingiva and periodontium. Linear gingival erythema, necrotizing ulcerative gingivitis and necrotizing ulcerative periodontitis have been described in HIV-infected patients. Initially, these diseases were considered specific for HIV infection. In recent years, however, it has become apparent that gingivitis and periodontitis in HIV-infected patients do not differ from those in immunocompetent individuals. AIDS-associated Kaposi's sarcoma (KS) predominantly occurs at the palate, the gingiva and the dorsum of the tongue. Histopathologically, oral KS is identical to classical KS. Oral KS has been treated surgically, using laser, radiotherapy and intralesional injections with chemo- and immunotherapy. After introduction of highly active antiretroviral therapy (HAART) oral manifestations, such as OC, gingivo-periodontitis and KS are rarely seen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  1. Anonymous (1993) Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on oral problems related to HIV infection and WHO collaborating centre on oral manifestations of the immunodeficiency virus. J Oral Pathol Med 22:289–291

    PubMed  Google Scholar 

  2. Blauvelt A (1999) The role of human herpesvirus 8 in the pathogenesis of Kaposi's sarcoma. Adv Dermatol 14:167–206

    CAS  PubMed  Google Scholar 

  3. Boshoff C, Whitby D, Talbot S, Weiss RA (1997) Etiology of AIDS-related Kaposi's sarcoma and lymphoma. Oral Dis 3 (Suppl I):129–132

    Google Scholar 

  4. Bossche H van den, Marichal P, Odds FC, et al (1992) Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 36:2602–2610

    PubMed  Google Scholar 

  5. Cassone A, De Bernardis F, Torosantucci A, Tacconelli E, Tumbarello M, Cauda R (1999) In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J Infect Dis 180:448–453

    Article  CAS  PubMed  Google Scholar 

  6. Cathomas G, Tamm M, McGandy CE, et al (1997) Transplantation-associated malignancies: restriction of human herpes virus 8 to Kaposi's sarcoma. Transplantation 64:175–178

    CAS  PubMed  Google Scholar 

  7. Cauda R, Tacconelli E, Tumbarello M, et al (1999) Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case control study. J AIDS 21:20–25

    CAS  Google Scholar 

  8. Coleman DC, Bennett DE, Gallagher PJ, et al (1995) Oral candidiasis and HIV infection: antifungal drug resistance and changes in Candida population dynamics. In: Greenspan JS, Greenspan D (eds) Oral manifestations of HIV infection. Quintessence, Chicago, pp 112–118

  9. Cross DL, Smith GLF (1995) Comparison of periodontal disease in HIV seropositive subjects and controls. II. Microbiology, immunology and predictors of disease progression. J Clin Periodontal 22:569–577

    CAS  Google Scholar 

  10. Deutsche Krebsgesellschaft e.V. (2000) Diagnose und Therapie des Kaposi Sarkoms. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft. (www.deutsche-krebsgesellschaft.de)

  11. Diz Dios P, Ocampo Hermida A, Miralles Alvarez C, Vázques Garcia E, Martínez Vázques C (1998) Regression of AIDS-related Kaposi's sarcoma following ritonavir therapy. Oral Oncol 34:236–238

    Article  PubMed  Google Scholar 

  12. Dodd CL, Greenspan D, Katz MH, et al (1991) Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS. AIDS 5:1339–1343

    CAS  PubMed  Google Scholar 

  13. Epstein, JB (1997) Management of oral Kaposi's sarcoma and proposal for clinical staging. Oral Dis 3 (Suppl I):124–128

    Google Scholar 

  14. Fichtenbaum CJ, Powderly WG (1998) Refractory mucosal candidiasis in patients with human immunodeficiency virus infection. Clin Infect Dis 26:556–565

    CAS  PubMed  Google Scholar 

  15. Flaitz CM, Nichols CM, Hicks MJ (1995) An overview of the oral manifestations of AIDS-related Kaposi's sarcoma. Compendium 16:136–138

    CAS  PubMed  Google Scholar 

  16. Fotos PG (1992) Oral candidosis. Clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 74:41–49

    CAS  PubMed  Google Scholar 

  17. Grbic JT, Mitchell-Lewis DA, Fine JB, et al (1995) The relationship of candidiasis to linear gingival erythema in HIV-infected homosexual men and parenteral drug users. J Periodontol 66:30–37

    CAS  PubMed  Google Scholar 

  18. Greenspan D (1994) Treatment of oral candidiasis in HIV infection. Oral Surg Oral Med Oral Pathol 78:211–215

    CAS  PubMed  Google Scholar 

  19. Hille JJ, Webster-Cyriaque J, Palefski JM, Raab-Traub N (2002) Mechanism of expression of HHV8, EBV and HPV in selected HIV-associated oral lesions. Oral Dis 8 (Suppl II):161–168

    Article  PubMed  Google Scholar 

  20. Holmstrup P, Westergaard J (1994) HIV associated periodontal diseases. In: Lang NP, Karring T (eds) Proceeding of the 1st European Workshop on Periodontology. Quintessence, London, pp 92–119

  21. Johnson NW (1997) Essential questions concerning periodontal diseases in HIV infection. Oral Dis 3 (Suppl I):138–140

    Google Scholar 

  22. Katz MH, Greenspan D, Westenhouse J, et al (1992) Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS 6:95–100

    CAS  PubMed  Google Scholar 

  23. Lamster IB, Grbic JT, Bucklan RS, Mitchell-Lewis D, Reynolds HS, Zambon JJ (1997) Epidemiology and diagnosis of HIV-associated periodontal diseases. Oral Dis 3 (Suppl I):141–148

    Google Scholar 

  24. Laskaris G, Hadjivassiliou M, Statigos J (1992) Oral signs and symptoms in 160 Greek HIV-infected patients. J Oral Pathol Med 21:120–123

    CAS  PubMed  Google Scholar 

  25. Luppi M, Barozzi P, Maiorana A, et al (1996) Frequency and distribution of herpesvirus-like DNA sequences (HHV8) in different stages of classic Kaposi's sarcoma and in normal tissues from an Italian population. Int J Cancer 66:427–431

    Article  CAS  PubMed  Google Scholar 

  26. McCarthy GM (1992) Host factors associated with HIV-related oral candidiasis. Oral Surg Oral Med Oral Pathol 73:181–186

    Google Scholar 

  27. Moniaci D, Greco D, Flecchia G, et al (1990) Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions. J Oral Pathol Med 19:477–481

    CAS  PubMed  Google Scholar 

  28. Natarajan U, Brummer E, Stevens DA (1997) Effect of granulocyte colony-stimulating factor on the candidacidal activity of polymorphonuclear neutrophils and their collaboration with fluconazole. Antimicrob Agents Chemother 41:1575–1578

    CAS  PubMed  Google Scholar 

  29. Nielsen H, Bentsen KD, Hojtved L, et al (1994) Oral candidiasis and immune status of HIV-infected patients. J Oral Pathol Med 23:140–143

    CAS  PubMed  Google Scholar 

  30. Orfanos CE, Husak R, Wolfer U, et al (1995) Kaposi's sarcoma: a reevaluation. Recent Results Cancer Res 139:275–296

    CAS  PubMed  Google Scholar 

  31. Pakker NG, Roos MT, Van Leeuwen R, et al (1997) Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents. J Acquir Immune Defic Syndr Hum Retrovirol 16:318–326

    CAS  PubMed  Google Scholar 

  32. Powderly WG, Gallant JE, Ghannoum MA, Mayer KH, Navarro EE, Perfect JR (1999) Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy. AIDS Res Hum Retroviruses 15:1619–1623

    Article  CAS  PubMed  Google Scholar 

  33. Poynton CH (1997) Immune modulation by cytokines in the treatment of opportunistic infections. Curr Opin Infect Dis 10:275–280

    Google Scholar 

  34. Ramírez-Amador V, Esquivel-Pedraza L, Lozada-Nur F, De la Rosa-García E, Volkow-Fernández P, Súchil-Bernal, Mohar A (2002) Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomised clinical trial. Oral Oncol 38:460–467

    Article  PubMed  Google Scholar 

  35. Reichart PA (1996) Oral pathology of acquired immunodeficiency syndrome and oro-facial Kaposi's sarcoma. Curr Top Pathol 90:97–123

    CAS  PubMed  Google Scholar 

  36. Reichart PA (1999) Clinical management of selected oral fungal and viral infections during HIV disease. Int Dent J 49:251–259

    CAS  PubMed  Google Scholar 

  37. Reichart PA, Langford-Kuntz A, Pohle HD (1993) Epidemic oro-facial Kaposi's sarcoma (eKS)—report on 124 cases. Oral Oncol Eur J Cancer 29B:187–189

    CAS  Google Scholar 

  38. Reichart PA, Schmidt-Westhausen AM, Samaranayake LP, Philipsen HP (1994) Candida-associated palatal papillary hyperplasia in HIV-infection. J Oral Pathol Med 23:403–405

    CAS  PubMed  Google Scholar 

  39. Renwick N, Halaby T, Weverling GJ, et al (1998) Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 12:2481–2488

    CAS  PubMed  Google Scholar 

  40. Reynolds HS, Haraszthy VI, Zambon JJ, et al (1996) Novel subgingival clostridial species associated with injecting drug users. J Dent Res 75:abstract 207

    Google Scholar 

  41. Robinson PG (2002) The significance and management of periodontal lesions in HIV infection. Oral Dis 8 (Suppl II):91–97

    Article  PubMed  Google Scholar 

  42. Robinson PG, Challacombe SJ, Sheiham A, Zakrzewska JM (1997) Is erythematous candidiasis associated with advanced HIV disease? Oral Dis 3 (Suppl I):116–118

    Google Scholar 

  43. Robinson PG, Sheiham A, Challacombe SJ, Zakrzewska JM (1997) Periodontal health and HIV infection. Oral Dis 3 (Suppl I):149–152

    Google Scholar 

  44. Rohrmus B, Thoma-Greber EM, Bogner JR, Röcken M (2000) Outlook in oral and cutaneous Kaposi's sarcoma. Lancet 356:2160

    Article  CAS  PubMed  Google Scholar 

  45. Samaranayake LP, Fidel PL, Naglik JR, Sweet SP, Teanpaisan R, Coogan MM, Blignaut E, Wanzala P (2000) Fungal infections associated with HIV infection. Oral Dis 8 (Suppl II):151–160

    Article  Google Scholar 

  46. Schmidt-Westhausen AM, Priepke F, Bergmann FJ, et al (2000) Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 29:336–341

    Article  CAS  PubMed  Google Scholar 

  47. Schulten EAJM, Ten Kate RW, Van der Waal I (1990) Oral findings in HIV-infected patients attending a department of internal medicine: the contribution of intraoral examination towards the clinical management of HIV disease. Q J Med 76:741–745

    CAS  PubMed  Google Scholar 

  48. Schöfer H (1998) Kaposi Sarkom. Hautarzt Suppl I:S39–S45

    Google Scholar 

  49. Scully C, Almeida OP de, Sposto MR (1997) The deep mycoses in HIV infection. Oral Dis 3 (Suppl I):200–207

    Google Scholar 

  50. Shirlaw PJ; Chikte U, MacPhail L, Schmidt-Westhausen AM, Croser D, Reichart PA (2002) Oral and dental care and treatment protocols for the management of HIV-infected patients. Oral Dis 8 (Suppl II):136–143

    Article  PubMed  Google Scholar 

  51. Tappero JW, Conant MA, Wolfe SF, et al (1993) Kaposi's sarcoma. J Am Acad Dermatol 28:371–395

    CAS  PubMed  Google Scholar 

  52. Tsai H, Bobek LA (1997) Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and resistant Candida species. Antimicrob Agents Chemother 41:2224–2228

    CAS  PubMed  Google Scholar 

  53. Warnock DW (1991) Amphotericin B: an introduction. J Antimicrob Chemother 28 (Suppl B):27–38

    CAS  PubMed  Google Scholar 

  54. Winkler JR, Murray PA (1987) Periodontal disease: a potential intraoral expression of AIDS may be a rapidly progressive periodontitis. Calif Dent Assoc J 15:20–24

    CAS  Google Scholar 

  55. Yarchoan R (1999) Therapy for Kaposi's sarcoma: recent advances and experimental approaches. J AIDS 21:566–573

    Google Scholar 

  56. Zingman BS (1996) Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir. N Engl J Med 334:1674–1675

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oral Surgery and Dental Radiology, Charité, Medical Faculty, Humboldt-University, Augustenburger Platz 1, 13353, Berlin, Germany

    Peter A. Reichart

Authors
  1. Peter A. Reichart
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter A. Reichart.

Additional information

Presented in part at the Joint Meeting of the 'Arbeitsgemeinschaft Dermatologische Infektiologie der Deutschen Dermatologischen Gesellschaft' and the 'Arbeitskreis Oralpathologie und Oralmedizin' on "Oral Viral Infection and Oral Tumors" in Rostock, Germany on 6–7 July 2001.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reichart, P.A. Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi's sarcoma. Med Microbiol Immunol 192, 165–169 (2003). https://doi.org/10.1007/s00430-002-0175-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00430-002-0175-5

Keywords

Search

Navigation